Greater Cannabis Company (GCAN) Liabilities and Shareholders Equity (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Liabilities and Shareholders Equity of $1439.0 in Q1 2026, up 76.56% quarter-over-quarter from $815.0 in Q4 2025, and down 96.89% on a YoY basis from $46213.0 in Q1 2025.
Greater Cannabis Company (GCAN) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $1439.0 for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 96.89% year-over-year to $1439.0; the TTM figure through Mar 2026 stood at $50321.0 (down 79.97% YoY), while the FY2025 annual figure was $815.0, down 98.59% from the prior year.
- Liabilities and Shareholders Equity was $1439.0 for Q1 2026 at Greater Cannabis Company, up from $815.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $381756.0 in Q1 2022 to a low of $815.0 in Q4 2025.
- Historically, Liabilities and Shareholders Equity has averaged $153525.2 across 5 years, with a median of $133490.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity climbed 2.45% in 2022, then plunged 98.59% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $280447.0 in 2022, then slumped by 38.57% to $172276.0 in 2023, then sank by 66.46% to $57785.0 in 2024, then slumped by 98.59% to $815.0 in 2025, then surged by 76.56% to $1439.0 in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $1439.0 (Q1 2026), $815.0 (Q4 2025), and $21355.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.35 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 2.27 Bn |
| 10 | Greater Cannabis Company | - | - | - | 1,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,439.00 |
| Dec 31, 2025 | 815.00 |
| Sep 30, 2025 | 21,355.00 |
| Jun 30, 2025 | 26,712.00 |
| Mar 31, 2025 | 46,213.00 |
| Dec 31, 2024 | 57,785.00 |
| Sep 30, 2024 | 63,949.00 |
| Jun 30, 2024 | 83,233.00 |
| Mar 31, 2024 | 133,490.00 |
| Dec 31, 2023 | 172,276.00 |
| Sep 30, 2023 | 206,199.00 |
| Jun 30, 2023 | 248,664.00 |
| Mar 31, 2023 | 260,720.00 |
| Dec 31, 2022 | 280,447.00 |
| Sep 30, 2022 | 300,761.00 |
| Jun 30, 2022 | 324,114.00 |
| Mar 31, 2022 | 381,756.00 |
| Dec 31, 2021 | 392,937.00 |
| Sep 30, 2021 | 509,775.00 |
| Jun 30, 2021 | 583,597.00 |